2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | SZU-MIN HSIEH ; Liu, Ming-Che; Chen, Yen-Hsu; Lee, Wen-Sen; Hwang, Shinn-Jang; Cheng, Shu-Hsing; Ko, Wen-Chien; Hwang, Kao-Pin; Wang, Ning-Chi; Lee, Yu-Lin; Lin, Yi-Ling; Shih, Shin-Ru; Huang, Chung-Guei; Liao, Chun-Che; Liang, Jian-Jong; Chang, Chih-Shin; Chen, Charles; Lien, Chia En; Tai, I-Chen; Lin, Tzou-Yien | The Lancet. Respiratory medicine | 87 | 81 | |
2023 | Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial | Estephan, Lila; Lin, Ying-Chin; Lin, Yi-Tsung; Chen, Yen-Hsu; SUNG-CHING PAN ; SZU-MIN HSIEH ; Torkehagen, Paal Fure; Weng, Yi-Jen; Cheng, Hao-Yuan; Estrada, Josue Antonio; Waits, Alexander; Chen, Charles; En Lien, Chia | Vaccine | 2 | 0 | |